Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

Therefore, the risk of ACD secondary to neomycin is increased when patients use neomycin on damaged skin such as atopic eczema, stasis dermatitis, lower leg ulcers, chronic venous insufficiency ...

Jazz and Werewolf's aim is to position WTX-613 as a safer alternative tipping the risk-to-benefit balance back in favour of treatment when used as both a monotherapy and in combination with other ...

This move would significantly bolster Stryker's portfolio, particularly in the treatment of venous thromboembolism and other related conditions. Inari has been actively exploring a sale after ...

Stryker's potential acquisition of Inari Medical highlights its ambition to bolster its position in the medical devices market, especially in venous disease treatments. With this purchase, Stryker ...

Your provider can also prescribe treatments or recommend a product you can buy over-the-counter (OTC) to help with your symptoms. 2. Irritant Contact Dermatitis Armpit rashes can also be caused by ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...